| Announce Date | 02/05/2026 |
| EPS Normalized Actual | $0.662 (Miss by $-0.378) |
| EPS GAAP Actual | $0.662 (Miss by $-0.378) |
| Revenue Actual | $1.28814B |
| Revenue Surprise | Beat by $1288.14M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.21408 |
| EPS GAAP Estimate | $1.21408 |
| Revenue Estimate | $1.431631793B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jun 2028 | 3.45399 | 7.26 | 3.39033 | 3.51504 | 1 |
| Jun 2027 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.57 | -0.55549 | 1.28814B | 1.49% | -117.03M |
| FQ2 2025 (Jun 2025) | 0.11 | 0.11 | 1.31054B | -103838.07% | 1310.54M |
| FQ1 2025 (Mar 2025) | 0.35 | 0.35 | 1.25436B | -15.37% | 1254.36M |
| FQ4 2024 (Dec 2024) | 0.87 | 0.87 | 1.3345B | -15.01% | 1334.5M |
| FQ3 2024 (Sep 2024) | 0.32 | 0.32 | 1.26901B | -12.33% | 1269.01M |
| FQ2 2024 (Jun 2024) | 915.37 | 915.37 | 1362.15B | 99.89% | 1362150M |
| FQ1 2024 (Mar 2024) | 0.36 | 0.36 | 1.44713B | 13.99% | 1447.13M |
| FQ4 2023 (Dec 2023) | 0.14 | 0.14 | 1.53487B | 41.53% | 1534.87M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
1.21408
Consensus Revenue Estimates
1.431631793B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 1.02215 | -- | 1.01243 | 1.02633 | 2 |
| FQ4 2027 (Dec 2027) | 1.29824 | -- | 1.28589 | 1.30355 | 1 |
| FQ3 2027 (Sep 2027) | 1.1087 | -- | 1.10445 | 1.11293 | 3 |
| FQ1 2027 (Mar 2027) | 1.28661 | -- | 1.27011 | 1.30635 | 3 |
| FQ4 2026 (Dec 2026) | 1.42733 | -- | 1.40903 | 1.44923 | 3 |
| FQ3 2026 (Jul 2026) | 1.14562 | 50.25 | 1.13994 | 1.14861 | 0 |
| FQ1 2026 (Mar 2026) | 1.21408 | 71.17 | 1.20196 | 1.23602 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 1.29B | -- | 1.28B | 1.3B | 2 |
| FQ4 2027 (Dec 2027) | 1.38B | -- | 1.37B | 1.38B | 3 |
| FQ3 2027 (Sep 2027) | 1.3B | -- | 1.29B | 1.3B | 3 |
| FQ1 2027 (Mar 2027) | 2.09B | -- | 2.07B | 2.12B | 4 |
| FQ4 2026 (Dec 2026) | 2.01B | -- | 1.99B | 2.04B | 4 |
| FQ3 2026 (Jul 2026) | 1.42B | 9.03 | 1.41B | 1.42B | 1 |
| FQ1 2026 (Mar 2026) | 1.43B | 12.38 | 1.42B | 1.45B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.12549 | 0.57 | -0.55549 | -97.45% |
| FQ2 2025 (Jun 2025) | 0.11 | 0.11 | 100% | |
| FQ1 2025 (Mar 2025) | 0.35 | 0.35 | 100% | |
| FQ4 2024 (Dec 2024) | 0.87 | 0.87 | 100% | |
| FQ3 2024 (Sep 2024) | 0.32 | 0.32 | 100% | |
| FQ2 2024 (Jun 2024) | 915.37 | 915.37 | 100% | |
| FQ1 2024 (Mar 2024) | 0.36 | 0.36 | 100% | |
| FQ4 2023 (Dec 2023) | 0.14 | 0.14 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.41B | $1.29B | $-117.03M | -9.09% |
| FQ2 2025 (Jun 2025) | $0B | $1.31B | $1310.54M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.25B | $1254.36M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.33B | $1334.5M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.27B | $1269.01M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1362.15B | $1362150M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.45B | $1447.13M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.53B | $1534.87M | 100% |